Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2026-03-13 00:00:00 ET · period of report 2026-03-11 · accession 0001780854-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-13 | 2026-03-11 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | S - Sale | $13.17 | -63.1K | 272.8K | -19% | -$831.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-11 | S | D | 63,103 | $13.17 | 272,751 | D | — | — |